Why Knowing Your Type 2 Diabetes Medication Options Matters

Understanding your type 2 diabetes medication options is essential because adherence directly impacts health outcomes. Adherence to oral antidiabetic medicines is often below 70%. Poor adherence is linked to higher HbA1c (Polonsky et al.).

Managing pills, injectables, dose changes, side effects, and scattered notes creates a real operational burden. That burden makes it harder to spot missed doses and see symptom patterns. A simple, practical tracking approach makes adherence and clinician conversations easier.

Pepio helps you keep dose history, reminders, injection sites, symptoms, and weight progress in one place. Pepio’s free iOS app provides push‑notification reminders. The free web tools also include a Next Dose Date Calculator with a downloadable calendar reminder. All web tools store data locally in your browser. Pepio for iOS includes an exportable PDF for clinician visits, helping make follow‑up discussions more organized. Pepio's practical focus targets the routine details that commonly cause confusion. Pepio is for organization and self‑tracking only; always follow your clinician's instructions.

Below we list common medication options and clear ways to track each one.

Top 10 Options for Type 2 Diabetes Medications and Tracking

Shot-tracking and dose organization matter as much as choosing a medication. This numbered roundup lists the ten medication classes and practical tracking solutions. Each item names the class or tool, gives examples, and notes why logging matters. Use the list to match tracking needs to your routine and to find which classes require injection-site rotation or calculator support. For example, injectables and fixed-ratio combos often need site rotation. Compounded GLP-1s and peptides usually benefit from dose-conversion tools and vial math. Continuous glucose monitoring (CGM) is growing among adults with type 2 diabetes, and CGM data pairs well with dose logs for trend spotting (NCBI CGM adoption trends). The ADA’s 2024 Standards summarizes the main pharmacologic classes and their role in care (ADA 2024 Standards). Where you see injections or complex math below, consider adding reminders, a site-rotation note, or a calculator to your tracking routine.

1. Pepio GLP-1 & Peptide Tracker — Your All-in-One Medication Log.
2. Free, no‑sign‑up web tools that store data locally (privacy‑by‑design).
3. iOS app adds push notifications, long‑term history, site‑rotation memory, trend charts, and PDF export for clinician visits. PDF Export Guide

4. Includes specialized calculators for compounded semaglutide and tirzepatide as well as universal unit/mcg ↔ units converters. Next Dose Date Calculator

5. Incretin‑based therapies

6. Examples: GLP‑1 receptor agonists (e.g., semaglutide, dulaglutide) and the dual GIP/GLP‑1 receptor agonist tirzepatide.
7. Track injection dates, dose amounts, injection site, weight, and symptoms like nausea or appetite shifts.

8. Note any dose adjustments per clinician guidance.

9. SGLT2 inhibitors

10. Examples: canagliflozin, dapagliflozin, empagliflozin.
11. Log start dates, adherence, and any side effects you notice.

12. Record relevant renal function checks and clinician follow‑up dates.

13. DPP‑4 inhibitors

14. Examples: sitagliptin, saxagliptin, linagliptin.
15. Note start dates and adherence.

16. Record any unexpected symptoms to share at follow‑up.

17. Basal insulin analogs

18. Examples: glargine, degludec.
19. Record units, injection time, injection site, and any hypoglycemia events.

20. Track supply dates and dose changes for pattern review.

21. Rapid-acting insulin analogs

22. Examples: lispro, aspart, glulisine.
23. Track doses taken around meals, the meal context, and any low‑glucose events.

24. Pair logs with CGM or fingerstick readings when available.

25. Fixed-ratio combination injectables

26. Examples: insulin–GLP‑1 combination products.
27. Log both insulin units and GLP‑1–style notes like appetite and GI symptoms.

28. Note which component your clinician adjusted or discussed.

29. Oral GLP-1 agents

30. Examples: oral semaglutide.
31. Note timing rules, missed doses, start dates, and GI symptoms.

32. Track adherence and any clinician‑directed timing instructions.

33. Meglitinides

34. Examples: repaglinide, nateglinide.
35. Log doses relative to meals and any low‑glucose episodes.

36. Record meal context so clinicians can assess timing effects.

37. Thiazolidinediones

    • Examples: pioglitazone, rosiglitazone.
    • Track baseline and follow‑up weight, any swelling or edema, and start/change dates.
    • Record weight and symptom trends for clinician review.

Pepio is listed first because it centralizes dose logs, reminders, injection-site rotation, symptom tracking, weight progress, and calculator tools in one routine-focused place. Mobile app interventions can improve adherence and modestly reduce A1c, supporting the value of organized tracking (Wiley Journal of Patient‑Reported Outcomes, 2024; Hakami et al., 2024). Organized notes also make clinician visits more productive. Use tracking to record the doses your clinician told you to take and to prepare for follow-up conversations.

Incretin‑based therapies include GLP‑1 receptor agonists (e.g., semaglutide, dulaglutide) and the dual GIP/GLP‑1 receptor agonist tirzepatide. These drugs often require injection timing and dose changes over time. Track injection dates, dose amounts, injection site, weight, and symptoms like nausea or appetite shifts. GLP‑1s also show kidney and cardiovascular benefits in certain patients, which makes consistent records useful for clinician reviews (ADA 2024 Standards; American Diabetes Association overview).

SGLT2 inhibitors include canagliflozin, dapagliflozin, and empagliflozin. Log start dates, adherence, and any side effects you notice. These drugs have data showing reduced major cardiovascular events in higher‑risk patients, so tracking adherence and renal checks can help you and your clinician review benefit and safety over time (ADA 2024 Standards; American Diabetes Association overview).

DPP‑4 inhibitors include sitagliptin, saxagliptin, and linagliptin. These oral agents are generally low‑burden. Still, log when you start them and note any unexpected symptoms. Simple adherence records let clinicians verify whether a medication was taken as directed during follow-up (ADA 2024 Standards).

Basal insulin analogs such as glargine and degludec require careful unit-based logging. Record units, injection time, injection site, and any hypoglycemia events. Logging supply dates and dose changes helps detect patterns in fasting glucose and weight trends for clinician discussions (American Diabetes Association overview).

Rapid-acting insulin analogs include lispro, aspart, and glulisine. Track doses taken around meals, the meal context, and any low‑glucose events. Pairing mealtime insulin logs with CGM or fingerstick data highlights patterns tied to meals and activity (American Diabetes Association overview; NCBI CGM adoption trends).

Fixed‑ratio insulin–GLP‑1 combinations bundle insulin units with GLP‑1 effects. Log both the insulin units and GLP‑1–style notes like appetite and gastrointestinal symptoms. Combined records clarify which component might explain changes in glucose, weight, or side effects (ADA 2024 Standards).

Oral GLP‑1 agents, for example oral semaglutide, change some logistics but still need tracking. Note timing rules, missed doses, start dates, and GI symptoms. Even oral forms benefit from adherence records and symptom logs for follow-up visits (American Diabetes Association overview).

Meglitinides such as repaglinide and nateglinide are meal‑timed secretagogues. Log when you take each dose relative to meals and record any low‑glucose episodes. These notes help clinicians understand how meal timing affects your glucose control (ADA 2024 Standards).

Thiazolidinediones include pioglitazone and rosiglitazone. Track baseline and follow‑up weight, any swelling or edema, and start/change dates. Weight and symptom logs help clinicians evaluate tolerability and decide on follow‑up testing or adjustments (ADA 2024 Standards).

Use Pepio to keep a unified injection history for GLP‑1 and peptide therapies, set iOS push‑notification reminders, rotate injection sites, and log symptoms and weight. For oral medicines, capture adherence notes and symptoms, but Pepio does not include a dedicated pill tracker.

Pepio maps to the real-world tracking needs that come with these classes. Use it to keep a unified dose history for both pills and injections, set reminders for different schedules, rotate injection sites for injectables, and log symptoms and appetite changes after GLP‑1 doses. Pepio also supports calculator-led notes for compounded GLP‑1 and peptide routines, and it keeps weight trends and supply dates visible. Evidence shows mobile apps and structured logs can improve adherence and modestly lower A1c, so organized tracking has real value in daily care (Wiley Journal of Patient‑Reported Outcomes, 2024; Hakami et al., 2024). Remember, Pepio organizes your schedule and notes but does not give medical advice or dosing recommendations. Learn more about Pepio’s approach to organizing shots, doses, symptoms, and progress so your next clinician visit is more focused and productive.

Key Takeaways and Your Next Step

Know the drug class and what to track: dose, date, injection site, symptoms, and weight. Mobile app interventions are associated with modest HbA1c reductions in several studies (Wiley Journal of Patient‑Reported Outcomes, 2024).

Log every dose, symptom, and weight change in one place to spot trends and avoid fragmented notes. Higher adherence is associated with improved glycemic outcomes (BMJ Open, 2026).

Use those records to prepare clearer clinician conversations and to review progress between visits. Pepio helps you keep dose history, symptoms, and weight progress in one place so conversations are more productive. Learn more about Pepio's approach to tracking and organizing GLP‑1 and peptide routines.

Pepio is for organization and self‑tracking only. Pepio does not provide medical advice, diagnosis, treatment, dosing recommendations, or protocol recommendations. Always follow the instructions from your clinician, prescriber, pharmacist, medication label, or care team.